Citi Pharma (KAR:CPHL) Receivables Turnover : 0.00 (As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is Citi Pharma Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Citi Pharma's Revenue for the six months ended in . 20 was ₨0.00 Mil. Citi Pharma's average Accounts Receivable for the six months ended in . 20 was ₨0.00 Mil.

Citi Pharma Receivables Turnover Historical Data

The historical data trend for Citi Pharma's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Citi Pharma Receivables Turnover Chart

Citi Pharma Annual Data

Trend

Receivables Turnover

Citi Pharma Semi-Annual Data

Receivables Turnover

Competitive Comparison of Citi Pharma's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Citi Pharma's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Citi Pharma's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Citi Pharma's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Citi Pharma's Receivables Turnover falls into.

Citi Pharma Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Citi Pharma's Receivables Turnover for the fiscal year that ended in . 20 is calculated as

	Receivables Turnover (A: . 20 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: . 20 )	/ (	(Accounts Receivable (A: . 20 )	+	Accounts Receivable (A: . 20 ))	/	count )
=		/ (	(	+	)	/	1 )
=		/	0
=	N/A

Citi Pharma's Receivables Turnover for the quarter that ended in . 20 is calculated as

	Receivables Turnover (Q: . 20 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: . 20 )	/ (	(Accounts Receivable (Q: . 20 )	+	Accounts Receivable (Q: . 20 ))	/	count )
=		/ (	(	+	)	/	1 )
=		/	0
=	N/A

Citi Pharma (KAR:CPHL) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Citi Pharma Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Citi Pharma's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Citi Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citi Pharma Ltd (KAR:CPHL) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

588 Q Block, Johar Town, Lahore, PB, PAK

Website

http://www.citipharma.com.pk

Citi Pharma Ltd is engaged in the manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. Its departments include Active Pharma Ingredients (API) and Formulations. Some of its products include Askprol C Tab, Lenon Tab, Recoz Tab, Cingol Tab among others.

Citi Pharma Headlines

No Headlines